| 摘要 |
A method for treating dyslipidemia in a human is disclosed, especially where the dyslipidemia is characterized by an HDL serum cholesterol level of below about 50 milligrams per deciliter. The method consists of the administration to said human of a therapeutically effective amount of 5-{(R)-1-hydroxy-2-[(R)-(1-methyl-3-phenylpropyl)amino]-ethyl}salicyla mide, 5-((S)-1-hydroxy-2-[(R)-(1-methyl-3-phenylpropyl)amino]ethyl}salicylamide or a pharmaceutically acceptable salt thereof or a mixture thereof. |
